Bridgewater Associates LP Cuts Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Bridgewater Associates LP lessened its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 74.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,876 shares of the health services provider's stock after selling 83,930 shares during the quarter. Bridgewater Associates LP's holdings in Teladoc Health were worth $262,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in TDOC. Vanguard Group Inc. raised its position in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after buying an additional 1,029,829 shares during the last quarter. Renaissance Technologies LLC grew its stake in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after acquiring an additional 763,265 shares in the last quarter. Geode Capital Management LLC increased its holdings in Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after acquiring an additional 22,664 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Teladoc Health by 18.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its holdings in shares of Teladoc Health by 21.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock valued at $6,365,000 after purchasing an additional 125,111 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.58% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on TDOC shares. Royal Bank of Canada lifted their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. The Goldman Sachs Group lowered their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Citigroup decreased their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research note on Friday. Piper Sandler reduced their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Teladoc Health has a consensus rating of "Hold" and an average target price of $10.71.

Teladoc Health Trading Down 0.5 %

TDOC stock traded down $0.04 during mid-day trading on Friday, reaching $7.23. The company had a trading volume of 784,790 shares, compared to its average volume of 6,221,653. The company has a market capitalization of $1.27 billion, a PE ratio of -1.25 and a beta of 1.73. The firm has a 50 day moving average of $8.63 and a 200 day moving average of $9.58. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.